These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 15848571

  • 1. No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation.
    Tellis V, Schechner R, Mallis M, Rosegreen S, Glicklich D, Moore N, Greenstein S.
    Transplant Proc; 2005 Mar; 37(2):906-8. PubMed ID: 15848571
    [Abstract] [Full Text] [Related]

  • 2. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK, Alloway RR, Roy-Chaudhury P, Mogilishetty G, Cardi MA, Weimert NA, Rike AH, First MR, Woodle ES.
    Transplantation; 2009 Feb 15; 87(3):408-14. PubMed ID: 19202447
    [Abstract] [Full Text] [Related]

  • 3. A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients.
    van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L.
    Transplantation; 2003 Jun 27; 75(12):1934-9. PubMed ID: 12829890
    [Abstract] [Full Text] [Related]

  • 4. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.
    Chan L, Hartmann E, Cibrik D, Cooper M, Shaw LM.
    Transplantation; 2010 Jul 15; 90(1):31-7. PubMed ID: 20517177
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A, Budde K, Clavien PA, Becker T, Kessler M, Pisarski P, Fornara P, Burmeister D, Hené RJ, Cassuto-Viguier E, SENIOR Study Team.
    Transplantation; 2009 Nov 15; 88(9):1101-8. PubMed ID: 19898206
    [Abstract] [Full Text] [Related]

  • 6. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 7. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov 15; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 8. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D.
    Transplant Proc; 2005 May 15; 37(4):1785-8. PubMed ID: 15919466
    [Abstract] [Full Text] [Related]

  • 9. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 15; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 10. Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
    Osuna A, Gentil MA, Capdevila L, Cantarell C, Mazuecos A, Pereira P, Rodríguez-Algarra G, González-Molina M, Spanish Kidney Transplant of Elderly Donor Study Group.
    Transplant Proc; 2005 Apr 15; 37(3):1438-40. PubMed ID: 15866630
    [Abstract] [Full Text] [Related]

  • 11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 12. Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.
    Chan L, Greenstein S, Hardy MA, Hartmann E, Bunnapradist S, Cibrik D, Shaw LM, Munir L, Ulbricht B, Cooper M, CRADUS09 Study Group.
    Transplantation; 2008 Mar 27; 85(6):821-6. PubMed ID: 18360262
    [Abstract] [Full Text] [Related]

  • 13. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.
    Carmellini M, Collini A, Ruggieri G, Garosi G, Bernini M.
    Transplant Proc; 2008 Mar 27; 40(6):1858-61. PubMed ID: 18675070
    [Abstract] [Full Text] [Related]

  • 14. Sirolimus (rapamycin) reduces the incidence of acute rejection episodes in renal transplantation: an initial experience in Taiwan.
    Liu KL, Chu SH, Chiang YJ, Wu CT, Chen Y.
    Transplant Proc; 2004 Sep 27; 36(7):2051-2. PubMed ID: 15518742
    [Abstract] [Full Text] [Related]

  • 15. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO.
    Transplant Proc; 2009 Sep 27; 41(6):2659-63. PubMed ID: 19715995
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).
    Trotter JF, Wachs M, Bak T, Trouillot T, Stolpman N, Everson GT, Kam I.
    Liver Transpl; 2001 Apr 27; 7(4):343-51. PubMed ID: 11303295
    [Abstract] [Full Text] [Related]

  • 17. Conversion to tacrolimus extended-release formulation: short-term clinical results.
    Gallego-Valcarce E, Ortega-Cerrato A, Llamas-Fuentes F, Martinez-Fernandez G, Perez-Martinez J, Gomez-Roldan C.
    Transplant Proc; 2009 Apr 27; 41(6):2326-7. PubMed ID: 19715909
    [Abstract] [Full Text] [Related]

  • 18. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 27; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 19. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.
    Boratyńska M, Banasik M, Patrzalek D, Szyber P, Klinger M.
    Transplant Proc; 2005 Mar 27; 37(2):839-42. PubMed ID: 15848550
    [Abstract] [Full Text] [Related]

  • 20. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Fukuhara N, Ono Y, Hattori R, Nishiyama N, Yamada S, Kamihira O, Kinukawa T, Ohshima S.
    Clin Transplant; 2005 Apr 27; 19(2):153-7. PubMed ID: 15740548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.